Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer
Subbiah, V., Shen, T., Tetzlaff, M., Weissferdt, A., Byers, L.A., Cascone, T., Behrang, A., Meric-Bernstam, F., Mooers, B.H.M., Rothenberg, S.M., Ebata, K., Wu, J.
Published in Annals of oncology (01.06.2021)
Published in Annals of oncology (01.06.2021)
Get full text
Journal Article
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer
Tran, H.T., Heeke, S., Sujit, S., Vokes, N., Zhang, J., Aminu, M., Lam, V.K., Vaporciyan, A., Swisher, S.G., Godoy, M.C.B., Cascone, T., Sepesi, B., Gibbons, D.L., Wu, J., Heymach, J.V.
Published in Annals of oncology (01.02.2024)
Published in Annals of oncology (01.02.2024)
Get full text
Journal Article
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
Ciardiello, F., Troiani, T., Bianco, R., Orditura, M., Morgillo, F., Martinelli, E., Morelli, M.P., Cascone, T., Tortora, G.
Published in Annals of oncology (01.06.2006)
Published in Annals of oncology (01.06.2006)
Get full text
Journal Article
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
Morgillo, F, Cascone, T, D'Aiuto, E, Martinelli, E, Troiani, T, Saintigny, P, De Palma, R, Heymach, J V, Berrino, L, Tuccillo, C, Ciardiello, F
Published in British journal of cancer (26.07.2011)
Published in British journal of cancer (26.07.2011)
Get full text
Journal Article
Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors
Nilsson, M B, Zage, P E, Zeng, L, Xu, L, Cascone, T, Wu, H K, Saigal, B, Zweidler-McKay, P A, Heymach, J V
Published in Oncogene (20.05.2010)
Published in Oncogene (20.05.2010)
Get full text
Journal Article
Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)
Weissferdt, A., Sepesi, B., Pataer, A., Kalhor, N., Moran, C.A., William, W.N., Le, X., Glisson, B., Skoulidis, F., Blumenschein, G., Zhang, J., Altan, M., Rice, D., Mehran, R., Lee, J.J., Vaporciyan, A., Gibbons, D.L., Swisher, S.G., Heymach, J.V., Cascone, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells
Xu, L, Nilsson, M B, Saintigny, P, Cascone, T, Herynk, M H, Du, Z, Nikolinakos, P G, Yang, Y, Prudkin, L, Liu, D, Lee, J J, Johnson, F M, Wong, K-K, Girard, L, Gazdar, A F, Minna, J D, Kurie, J M, Wistuba, I I, Heymach, J V
Published in Oncogene (06.05.2010)
Published in Oncogene (06.05.2010)
Get full text
Journal Article
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
Morelli, M.P., Cascone, T., Troiani, T., De Vita, F., Orditura, M., Laus, G., Eckhardt, S.G., Pepe, S., Tortora, G., Ciardiello, F.
Published in Annals of oncology (01.05.2005)
Published in Annals of oncology (01.05.2005)
Get full text
Journal Article
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
Cascone, T., Sacks, R.L., Subbiah, I.M., Drobnitzky, N., Piha-Paul, S.A., Hong, D.S., Hess, K.R., Amini, B., Bhatt, T., Fu, S., Naing, A., Janku, F., Karp, D., Falchook, G.S., Conley, A.P., Sherman, S.I., Meric-Bernstam, F., Ryan, A.J., Heymach, J.V., Subbiah, V.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
Get full text
Journal Article
Conference Proceeding
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)
Cascone, T., William, W.N., Weissferdt, A., Leung, C.H., Federico, L., Haymaker, C., Bernatchez, C., Fossella, F.V., Mott, F.E., Papadimitrakopoulou, V.A., Byers, L., Lam, V.K., Godoy, M.C., Carter, B., Lee, J.J., Vaporciyan, A., Gibbons, D.L., Swisher, S.G., Heymach, J.V., Sepesi, B.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer
Iovino, F., Ferraraccio, F., Orditura, M., Antoniol, G., Morgillo, F., Cascone, T., Diadema, M. R., Aurilio, G., Santabarbara, G., Ruggiero, R., Belli, C., Irlandese, E., Fasano, M., Ciardiello, F., Procaccini, E., Lo Schiavo, F., Catalano, G., De Vita, F.
Published in Cancer investigation (01.01.2008)
Published in Cancer investigation (01.01.2008)
Get full text
Journal Article
PL02.08 Perioperative vs Neoadjuvant Nivolumab for Resectable NSCLC: Patient-Level Data Analysis of CheckMate 77T vs CheckMate 816
Forde, P.M., Peters, S., Donington, J., Meadows-Shropshire, S., Tran, P., Lucherini, S., Coronado Erdmann, C., Sun, H., Cascone, T.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
P1.25-02 Complete Pathologic Response (pCR) as a Surrogate Endpoint in Neoadjuvant Immunotherapy Clinical Trials for NSCLC: A Meta-analysis
Hines, J., Cameron, R., Torri, V., Cascone, T., Forde, P.M., Esposito, A., Vokes, E., Bestvina, C., Marina, G.C., Porcu, L.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
Comorbidities and Their Impact on Treatment Tolerance and Outcome in Elderly NSCLC Patients Treated with Concurrent Chemoradiation Using Proton or Photon Followed by Immunotherapy
Sasaki, Y.M., Xu, T., Koutroumpakis, S., Sheshadri, A., Deswal, A., Nguyen, Q.N., Gandhi, S., Cascone, T., Le, X., Altan, M., Chen, A.B., Liao, Z.
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Get full text
Journal Article
2334P Pathologic patterns following different neoadjuvant therapies in non-small cell lung cancer (NSCLC)
Weissferdt, A., Leung, C.H., Sepesi, B., Nassib William Junior, W., Lin, H., Mehran, R., Gibbons, D.L., Vaporciyan, A., Heymach, J., Swisher, S., Lee, J.J., Cascone, T., Pataer, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study
Provencio Pulla, M., Awad, M., Cascone, T., Spicer, J.D., He, J., Lu, S., Alexandru, A., Watanabe, Y., Cornelissen, R., Koch, L.D.O., Kuzdzal, J., Pujol, J-L., Hoffknecht, P., Gray, J.E., Coronado Erdmann, C., Neely, J., Devas, V., Bhatia, S., Tanaka, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1232P Assessing uncertainty and vulnerability of clinical trials with immune-checkpoint inhibitors and chemotherapy (ICI+CT) in early stage non-small cell lung cancer (NSCLC) by informative censoring and survival inferred fragility index (SIFI)
Nuccio, A., Salomone, F., Viscardi, G., Venanzi, F.M., Bulotta, A., Ogliari, F.R., Oresti, S., Riva, S.T., Mollica, L., Viganò, M.G., Passaretti, F., Ravasi, M., Papotto, L., Ferrara, M., Ricciuti, B., Veronesi, G., Cascone, T., Garassino, M.C., Torri, V., Ferrara, R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Combination Immune Checkpoint Blockade Promising in Operable NSCLC
Published in Cancer discovery
(01.05.2021)
Get full text
Journal Article
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
Federico, L., McGrail, D.J., Bentebibel, S.-E., Haymaker, C., Ravelli, A., Forget, M.-A., Karpinets, T., Jiang, P., Reuben, A., Negrao, M.V., Li, J., Khairullah, R., Zhang, J., Weissferdt, A., Vaporciyan, A.A., Antonoff, M.B., Walsh, G., Lin, S.-Y., Futreal, A., Wistuba, I., Roth, J., Byers, L.A., Gaudreau, P.-O., Uraoka, N., Cruz, A.F., Dejima, H., Lazcano, R.N., Solis, L.M., Parra, E.R., Lee, J.J., Swisher, S., Cascone, T., Heymach, J.V., Zhang, J., Sepesi, B., Gibbons, D.L., Bernatchez, C.
Published in Annals of oncology (01.01.2022)
Published in Annals of oncology (01.01.2022)
Get full text
Journal Article